CN104435509B - A kind of Chinese medicine composition for treating newborn addiction and preparation method thereof - Google Patents
A kind of Chinese medicine composition for treating newborn addiction and preparation method thereof Download PDFInfo
- Publication number
- CN104435509B CN104435509B CN201410269639.XA CN201410269639A CN104435509B CN 104435509 B CN104435509 B CN 104435509B CN 201410269639 A CN201410269639 A CN 201410269639A CN 104435509 B CN104435509 B CN 104435509B
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- minutes
- rhizome
- rascal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 82
- 206010012335 Dependence Diseases 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims description 36
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 25
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 25
- 235000014290 Artemisia anomala Nutrition 0.000 claims abstract description 24
- 241000123844 Artemisia anomala Species 0.000 claims abstract description 24
- 241000132012 Atractylodes Species 0.000 claims abstract description 22
- 241000903946 Clematidis Species 0.000 claims abstract description 21
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 21
- 239000000341 volatile oil Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 17
- 235000021419 vinegar Nutrition 0.000 claims description 17
- 239000000052 vinegar Substances 0.000 claims description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000001256 steam distillation Methods 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 8
- 238000003809 water extraction Methods 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 5
- 239000004570 mortar (masonry) Substances 0.000 claims description 3
- 235000007756 Akebia quinata Nutrition 0.000 claims 2
- 240000008027 Akebia quinata Species 0.000 claims 2
- 239000002304 perfume Substances 0.000 claims 2
- 235000013599 spices Nutrition 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 35
- 230000036407 pain Effects 0.000 description 34
- 210000004185 liver Anatomy 0.000 description 19
- 210000000481 breast Anatomy 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000037093 Menstruation Disturbances Diseases 0.000 description 5
- 206010027339 Menstruation irregular Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000010415 tropism Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000004080 punching Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 241000218158 Clematis Species 0.000 description 2
- 241000786785 Clematis montana Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000522620 Scorpio Species 0.000 description 2
- 235000008326 Trichosanthes anguina Nutrition 0.000 description 2
- 244000078912 Trichosanthes cucumerina Species 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- -1 apiolin Chemical compound 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 239000009490 scorpio Substances 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- NTWLPZMPTFQYQI-UHFFFAOYSA-N (3alpha)-olean-12-ene-3,23-diol Natural products C1CC(O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C NTWLPZMPTFQYQI-UHFFFAOYSA-N 0.000 description 1
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 1
- ZHESTCBHMHKZNL-UHFFFAOYSA-N 5,7-dihydroxy-6-methoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(O)=C(OC)C(O)=C3C(=O)C=2)=C1 ZHESTCBHMHKZNL-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010006272 Breast mass Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000601164 Clematis orientalis Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164480 Curcuma aromatica Species 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- GCGBHJLBFAPRDB-UHFFFAOYSA-N Hederagenin Natural products CC1(C)CCC2(CCC3(C)C4CCC5C(C)(CO)C(O)CCC5(C)C4CC=C3C2C1)C(=O)O GCGBHJLBFAPRDB-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241001408874 Juncus acutiflorus Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241001339782 Scapharca broughtonii Species 0.000 description 1
- GCGBHJLBFAPRDB-KCVAUKQGSA-N Scutellaric acid Natural products CC1(C)CC[C@@]2(CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2C1)C(=O)O GCGBHJLBFAPRDB-KCVAUKQGSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000011279 abdominal lump Diseases 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ZZDWUECZDPGSPL-UHFFFAOYSA-N arteanoflavone Natural products COc1cc(cc(O)c1OC)-c1cc(=O)c2c(OC)c(OC)c(O)cc2o1 ZZDWUECZDPGSPL-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 201000004535 ovarian dysfunction Diseases 0.000 description 1
- 231100000543 ovarian dysfunction Toxicity 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for treating newborn addiction, the primary raw material of following weight proportions is taken to be prepared from:15 30 parts of Artemisia anomala, 20 30 parts of row night, 18 25 parts of latifolious rush rhizome, 10 20 parts of rascal, 9 28 parts of caulis clematidis armandii, 30 40 parts of the bighead atractylodes rhizome, 25 40 parts of Ligusticum wallichii, 9 18 parts of radix bupleuri, 6 14 parts of safflower, 15 28 parts of rhizoma cyperi.Chinese medicine composition of the present invention meets the principle that traditional Chinese medicine debates disease treatment.The medicinal material of selection is divided into particle for oral administration and external application application volatile oil, inside and outside to treat simultaneously, treats more comprehensive, rapider, lasting medicine is administered in affected area, belongs to inside and outside and take into account, the newborn addiction prescription treated both principal and secondary aspect of disease.The Chinese medicinal material of selection has promoting blood circulation and removing blood stasis, relaxes the muscles and stimulate the blood circulation, the effect of qi-regulating with, and cheap, and the financial burden for also not resulting in patient is used for a long time, and is the ideal medicine of the newborn addiction for the treatment of.
Description
Technical field
The invention belongs to traditional Chinese medicine field, it is related to a kind of Chinese medicine composition for treating newborn addiction and preparation method thereof.
Background technology
Newborn addiction:Disease of tcm name, refers to the common chronic benign lump in female breast portion, based on lump in breast and distending pain
Disease, is common in young women.Newborn addiction is found in hyperplasia of mammary glands, Cystic hyperplasia of breast, mastofibroma of western medicine etc.
Disease.Western medicine thinks that cyclomastopathy is relevant with ovarian dysfunction, and such as lutern, which is secreted, to be reduced, the Secretion pair of estrogen
Increase.
This disease is how angry relevant with feelings will internal injury, troubled thoughts.Stomach of foot Yang Ming passes through under breast, the liver channel of foot-Jueyin to breast, and foot is too
Cloudy the spleen channel row breast is outer, if feelings will internal injury, and angry then liver and spleen pent-up of being worried, qi and blood is inverse disorderly, and the not all right Tianjin of gas, body fluid is condensed into phlegm;It is multiple
Because of liver Wood restricts earth, spleen is caused to transport wet, stomach can not drop turbid, then the turbid interior life of phlegm;Turbid hinder in newborn network of stagnation of the circulation of vital energy phlegm is then lump pain.Eight
Arteries and veins is subordinate in liver kidney, and chong channel is subordinate in positive bright, if liver depression forming fire, consumes the moon of liver kidney, then Chong and Ren channel disorder,《General Records of Holy Universal Relief》Cloud:" punching is appointed
Two warps, are above milk, and lower is moon water." so this disease is how related to the menstrual cycle.This sick basic pathogenesis is solidifying for stagnation of the circulation of vital energy phlegm, punching
Appoint imbalance, disease is passed through in stomach, liver, spleen three.There is shape lump not of uniform size with breast, pain is related as mainly with the menstrual cycle
The mastosis class disease of performance.
This disease is more common in 20-40 Sui women, show as unilateral or bilateral breast occur it is single or multiple differ in size it is swollen
Block, distending pain or tenderness, surface are smooth, clear border, push away movable, increases slowly, strong but pliable in texture or sexy in capsule.It is simultaneous to see lump
Often disappear elder because liking anger with distending pain, card category stagnation of the circulation of vital energy phlegm coagulates;Then it is punching if often being aggravated before menstruation comes, alleviator after menstruation
Appoint imbalance.Majority has a flat lump in breast outside upper quadrant, and that lays one's hand on has the tough hard tubercle of beans size, can there is tenderness, lump side
Boundary owes clear, with surrounding tissue adhesion.Breast can have distending pain or shouting pain, anger of often joining in charitable and pious deeds and growth and decline, and the moon is premenstrual to be aggravated, and is delayed after menstruation
Solution.
The Syndrome Types of TCM of newborn addiction is a lot of, point two types having, point three types having, until four types, five types, six types, seven types etc., very
Or more.What is had is excessively simple, and what is had is too numerous.But always coagulated nothing more than stagnation of QI due to depression of the liver, stagnation of the circulation of vital energy phlegm, blood stasis phlegm is solidifying, discord, a spleen kidney yang are appointed in punching
Void, the deficiency of liver-yin and kidney-yin, qi-blood deficiency etc..Though the opinion of each family is not the same, its interpretation of the cause, onset and process of an illness all be unable to do without above-mentioned viewpoint.Li Jimin
Doctor treats newborn addiction (cyclomastopathy), and clinically the dialectical four types progress opinion that is divided into is controlled.
1. stagnation of QI due to depression of the liver:Liver depression is not relaxed, breast fullness, and caking distending pain is joined in charitable and pious deeds anger growth and decline, when have shouting pain, two side of body distending pains, mouth
Bitter irritated, pale tongue with thin fur is white, veins string or thin string.2. Chong and Ren channel disorder:Breast lumps, secret anguish or shouting pain, fixed pain.Premenstrual lump
Significantly increase, reduce after and soften, or with the disease such as irregular menstruation, dysmenorrhoea, infertile.Pink tongue tongue is white, and arteries and veins carefully moistens.3. insufficiency of the spleen phlegm
It is solidifying:Lump in breast is larger, but slow-growing, and matter heavily fortified point distending pain, surface is smooth, and what is pushed away is removable, and clear border, mammary contour is constant.
Thin white fur of tongue, wiry and rolling pulse.Kidney deficiency blood stasis:With the passing of time breast is lumpd, and shouting pain or has a dull ache, and sore spot is fixed.It is weak with the soreness of waist, through water
Less and color is light, or the disease such as amenorrhoea, infertile.Tongue is dark or there are petechia, the thin white, deep thready pulse of tongue in tongue side.
In the method for the newborn addiction of existing treatment, the B of Authorization Notice No. CN 102671113 (application number 201210066880.3)
Patent disclose a kind of preparation method for the Chinese medicine composition for treating newborn addiction, take the crude drug of following parts by weight:Oyster 130-
160 parts, 210-250 parts of the Radix Astragali, 20-40 parts of Rhizoma Sparganii, 20-30 parts of malt, 140-170 parts of asparagus fern, 50-70 parts of myrrh, barrenwort
140-170 parts, 140-170 parts of the red sage root, 20-40 parts of the bighead atractylodes rhizome, 140-170 parts of marine alga, 20-40 parts of radix bupleuri, 20-40 parts of curcuma zedoary, chicken
Interior golden 30-50 parts, 20-40 parts of rascal, 20-40 parts of frankincense;Authorization Notice No. CN 101244177B's (200810049393.X)
Patent disclose a kind of newborn addiction dissipate and preparation method thereof, by 3-5 grams of scorpio, 3-5 grams of rhizoma cyperi, 3-5 grams of blood clam, 3-5 grams of safflower,
Full Snakegourd Fruit 400-500 restrains into;Its preparation method is realized by following steps:First by 3-5 grams of scorpio, 3-5 grams of rhizoma cyperi, watt
Stupefied sub- 3-5 grams, 3-5 grams of safflower be ground into powder, secondly fresh full 400-500 grams of Snakegourd Fruit is added water is brewed into flowing soaking paste, then
Dried, be made powdered, finally the powder of said medicine is well mixed, that is, the present invention is made.
Chinese medicine has good curative effect in the newborn addiction for the treatment of as can be seen here, but at present in the medicine of the newborn addiction of existing treatment,
General comparitive study is single, and therapeutic effect is also bad, and extra burden can be caused to the body of patient.
The content of the invention
For the present situation that the newborn addiction of existing treatment is not enough, an object of the present invention is to provide a kind of Chinese medicine for treating newborn addiction
Composition, with easy to carry, action effect substantially, can be quickly play effect promoting blood circulation and removing blood stasis, and it is using in the localities
Relatively conventional Chinese medicine is with low cost as raw material.
Another object of the present invention is just to provide the preparation method of above-mentioned Chinese medicine composition.
The above-mentioned purpose of the present invention is achieved through the following technical solutions:
A kind of Chinese medicine composition for treating newborn addiction, takes the primary raw material of following weight proportions to be prepared from:Artemisia anomala 15-30
Part, night 20-30 parts of row, 18-25 parts of latifolious rush rhizome, 10-20 parts of rascal, 9-28 parts of caulis clematidis armandii, 30-40 parts of the bighead atractylodes rhizome, Ligusticum wallichii 25-40
Part, 9-18 parts of radix bupleuri, 6-14 parts of safflower, 15-28 parts of rhizoma cyperi.
A kind of Chinese medicine composition for treating newborn addiction, optimum ratio takes the primary raw material of following weight proportions to be prepared from:Liu
Post 23-26 parts of slave, night 23-28 parts of row, 20-22 parts of latifolious rush rhizome, 13-18 parts of rascal, 15-18 parts of caulis clematidis armandii, 33-38 parts of the bighead atractylodes rhizome,
30-35 parts of Ligusticum wallichii, 13-15 parts of radix bupleuri, 9-11 parts of safflower, 23-25 parts of rhizoma cyperi.
A kind of Chinese medicine composition for treating newborn addiction, more preferably preferred proportioning takes the primary raw material of following weight proportions to prepare
Form:24 parts of Artemisia anomala, 25 parts of row night, 21 parts of latifolious rush rhizome, 15 parts of rascal, 16 parts of caulis clematidis armandii, 35 parts of the bighead atractylodes rhizome, 33 parts of Ligusticum wallichii, bavin
14 parts recklessly, 10 parts of safflower, 24 parts of rhizoma cyperi.
The preparation method of above-mentioned Chinese medicine composition, scheme preferably is:Step is as follows:
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 20-40 minutes slowly as low baking temperature on tile, taking-up dries in the air cool,
Mortar pulverization is used, 130-150 mesh sieves (preferably crossing 140 mesh sieves) are crossed;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar is row night, bavin
Recklessly with 1-3 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 1-5 times of bulk drug weight, 80 DEG C with
Upper water extraction 40-80 minutes (preferably water extraction 60 minutes), crosses 100-200 mesh screen packs, obtains decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 80-120 mesh sieves (preferably 100 mesh sieves), plus 30-40 DEG C of warm water soaks 30 points
Clock, intense fire is fried open, and is turned slow fire heating distillation equipment and is collected distillate or be passed through steam distillation 50-70 minutes, makes volatile oil
Together distilled with water, collect distillate, stand 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, added in fluid
Enter safflower and be heated to 80 DEG C -150 DEG C, keep 6 minutes sterilizings, be cooled to room temperature, after be distributed into air-tight bottle and obtain external application application
Volatile oil.
Above-mentioned preparation method, scheme preferably is:Step (1) by Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii as watt
Low baking temperature dries 25-35 minutes (preferably 30 minutes) slowly on piece.
Above-mentioned preparation method, scheme preferably is:The consumption of step (2) light-coloured vinegar is row night, radix bupleuri and the total consumption of rhizoma cyperi
1.5-2.5 times (preferably 2 times).
Above-mentioned preparation method, scheme preferably is:Step (3) water consumption is 2-4 times (preferably 3 of bulk drug weight
Times).
Above-mentioned preparation method, scheme preferably is:Step (3) crosses 140-180 mesh screen pack, and (preferably 160 mesh are filtered
Net).
Above-mentioned preparation method, scheme preferably is:Step (6) is passed through steam distillation 55-65 minutes (preferably 60 points
Clock).
Above-mentioned preparation method, scheme preferably is:Safflower is added in step (6) fluid and is heated to 100-130 DEG C (preferably
It is heated to 120 DEG C).
Application method:To make the present invention reach optimum therapeuticing effect, gained granule is taken after 1 hour after the meal three, used
Warm boiled water, each 3-5 grams, gained external application application volatile oil is applied at mammary swelling, and one for several times, appropriate every time, is within 7 days
One course for the treatment of.
The Chinese medicine composition is notable to the effect of newborn addiction, and not only promoting blood circulation and removing blood stasis, moreover it is possible to relax the muscles and stimulate the blood circulation, recuperating qi-blood improves
Patient is for a long time because of the slight illness that newborn addiction is brought, and the optionally common medicinal materials in side more than the present invention, cheap, alleviates the economy of patient
Burden.
A kind of Chinese medicine composition for treating newborn addiction, the pharmacological effect of each bulk drug is respectively:
Artemisia anomala:Also known as Artemisia anomala grass, Herba Senecionis Scandentis, it is the wounded in the battle herb of composite family sagebruss artemisia anomalas.The property of medicine:Stem cylinder
Shape, surface brown color or brown-green, matter are hard and crisp, frangibility, the integrated spike panicle of capitulum, withered yellow, gas fragrance,
It is bitter, pungent, it is warm-natured.Composition:Mainly contain arteanoflavone, tricin, apiolin, palmitic acid etc..According to modern pharmacological research
It was found that, the medical instrument has functions that anti anoxia, promoting blood circulation and removing blood stasis, disperse accumulations, hemostasia and detumescence, for amenorrhea due to stagnation of blood, dyspeptic abdominalgia, hematuria,
The diseases such as scald.
Row night:Base:The full worm that cape belongs to animal tiger spot cloth cape is walked for Carabidae.The property of medicine:It is pungent, temperature.Function is cured mainly:Promoting blood circulation
Stagnation resolvation, eliminating stagnation to stop pain.Cure mainly amenorrhea due to stagnation of blood, dysmenorrhoea, postpartum stasis of blood, a lump in the abdomen causing distension and pain, bruise stasis caused pain.
Latifolious rush rhizome:Base:The rhizome of stem rush is walked for rush family sharp-flowered rush plant.The property of medicine:It is mild-natured, it is pungent, micro-
It is bitter.Function is cured mainly:Regulating qi-flowing for relieving pain, regulating menstruation and activating blood is cured mainly under stagnation of QI due to depression of the liver, pain in chest and hypochondrium, menstrual disorder, metrorrhagia band.
Rascal:Base:For Rutaceae citrus tree plant tangerine and its young fruit or the pericarp of immature fruit of variety.Into
Point:Rascal active ingredient containing boosting:Left-handed synephrine acetate;Also contain aspartic acid, glutamic acid, proline, glycine, the third ammonia
Acid, cystine, leucine, isoleucine, phenylalanine etc..The property of medicine:It is bitter, pungent, temperature.Return liver, courage, stomach.Function is cured mainly:It is soothing the liver
Relieving stagnant Qi, disperse accumulationsization is stagnant.Cure mainly side of body rib, breast, epigastric distending pain, newborn core, acute mastitis, hernia, dyspepsia, a lump in the abdomen causing distension and pain, chronic malaria addiction block.
Caulis clematidis armandii:Base:For the rattan of Ranunculaceae Actions of Clematis Species mandarin clematis herb, Clematis montana etc..Composition:1. mandarin clematis herb contains
Brass methods of glycosides:Root of Chinese clematis glycosides.2. Clematis montana contains the six sugared saponin(es and trisaccharide saponin(e using hederagenin as aglycon.Medicine
Property:Light, slight bitter, trembles with fear.Function is cured mainly:Reducing fever and causing diuresis, stimulate the menstrual flow lower breast.The damp and hot retention of urine is cured mainly, oedema, stranguria, aphthae is damp and hot
Numbness pain, articular instability, married woman's amenorrhoea, alactation.
The bighead atractylodes rhizome:Nature and flavor:It is bitter, sweet, temperature.Channel tropism:Returns spleen, stomach.Effect:Strengthening the spleen and replenishing qi, eliminate dampness and have diuretic effect, hidroschesis is antiabortive.It is main
Control:For spleen eating less, abdominal distention diarrhea, phlegm retention anti-dazzle nervous, oedema, spontaneous perspiration, fetal irritability.Rhizoma Atractylodis Macrocephalae invigorating the spleen, and stomach, it is antiabortive.With
In spleen eating less, having loose bowels just clear, fetal irritability.
Ligusticum wallichii:Nature and flavor:It is pungent, temperature.Channel tropism:Return liver, courage, pericardium channel.Effect:Blood-activating and qi-promoting, wind-expelling pain-stopping.Cure mainly:For
Irregular menstruation closed dysmenorrhea , Disorder lump in the abdomen is suffered from abdominal pain, chest side of body shouting pain, tumbling and swelling, headache.Arthralgia pain due to rheumatism.
Radix bupleuri:Nature and flavor:Hardship, is slightly cold.Channel tropism:Return liver, gallbladder channel.Effect:It is soothing the liver in inducing diaphoresis, rising Yang.Cure mainly:For feeling
Emit heating fevers and chills alternates, distending pain in the chest and hypochondrium, irregular menstruation;The prolapse of uterus, prolapse of the anus.
Safflower:Nature and flavor:It is pungent, temperature.Channel tropism:The thoughts of returning home, Liver Channel.Effect:Invigorate blood circulation, blood stasis removing analgesic.Cure mainly:For Amenorrhea,
Dysmenorrhoea, lochia , abdominal lump of mass in abdomen, injury from falling down, sore swell and ache curative.
Rhizoma cyperi:Nature and flavor:Pungent, slight bitter, micro-sweet, put down.Channel tropism:Return liver, spleen, tri-jiao channel.Effect:Promoting qi circulation and removing obstruction in the collateral, menstruction regulating and pain relieving.
Cure mainly:For stagnation of QI due to depression of the liver, chest, the side of body, abdominal distention, indigestion, chest gastral cavity ruffian, cold hernia stomachache, swollen breasts, menstruation is not
Adjust, closed dysmenorrhea.
Chinese medicine composition of the present invention meets the principle that traditional Chinese medicine debates disease treatment.The medicinal material of selection is divided into particle for oral administration and outer
It is inside and outside to treat simultaneously with application volatile oil, treat more comprehensive, rapider, lasting medicine is administered in affected area, belong to inside and outside simultaneous
Turn round and look at, the newborn addiction prescription treated both principal and secondary aspect of disease.The Chinese medicinal material of selection has promoting blood circulation and removing blood stasis, relaxes the muscles and stimulate the blood circulation, the effect of qi-regulating with, and makes
Valency is cheap, and the financial burden for also not resulting in patient is used for a long time, and is the ideal medicine of the newborn addiction for the treatment of.
Embodiment
Technical scheme is described in detail with reference to embodiment and experimental example, but protection domain is not limited by this.
A kind of Chinese medicine composition for treating newborn addiction of embodiment 1, takes the primary raw material of following weight proportions to be prepared from (often
Part takes 20g):15 parts of Artemisia anomala, 20 parts of row night, 18 parts of latifolious rush rhizome, 10 parts of rascal, 9 parts of caulis clematidis armandii, 30 parts of the bighead atractylodes rhizome, 25 parts of Ligusticum wallichii,
9 parts of radix bupleuri, 6 parts of safflower, 15 parts of rhizoma cyperi.
The preparation method of above-mentioned Chinese medicine composition, step is:
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 20 minutes slowly as low baking temperature on tile, taking-up dries in the air cool, with grinding
Alms bowl pulverization, crosses 130 mesh sieves;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar is row night, bavin
Recklessly with 1 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 1 times, more than 80 DEG C of bulk drug weight
Water extraction 40 minutes, crosses 100 mesh screen packs, obtains decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 80 mesh sieves, plus 30 DEG C of warm water soaks 30 minutes, intense fire is fried open, and turns slow fire heating
Distillate is collected with distillation equipment or steam distillation is passed through 50 minutes, volatile oil is together distilled with water, collects distillation
Liquid, stands 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, and safflower is added in fluid and is heated to 80 DEG C, is kept for 6 minutes
Sterilizing, is cooled to room temperature, after be distributed into air-tight bottle obtain external application application volatile oil.
Zou XX of model case one, female, 32 years old, Jinan City, Shandong Province personage, in December, 2012 morbidity, patient's readme:Usually go out
Existing mood is had some setbacks, and is hard and dry, the symptom such as breast fullness, touches with lump with hand, and caking distending pain is joined in charitable and pious deeds anger growth and decline, when spinosity
Bitterly, two side of body distending pain, always bitter taste of waking up morning goes to register the department of Chinese medicine, and doctor sees that its face is intense darkness without light, and pale tongue with thin fur is white, by pair
Patient is inquired, is diagnosed as newborn addiction, and because patient thinks expectant treatment, doctor's suggestion is taken and with the use of Chinese traditional medicine composition of the present invention
Thing.
Take and use cooperatively 1 resulting composition of embodiment after 5 days, malaise symptoms start to mitigate, after 2 courses for the treatment of patient from
Sense recovery from illness, consolidates 2 courses for the treatment of after recovery from illness, be discontinued so far without recurrence.
A kind of Chinese medicine composition for treating newborn addiction of embodiment 2, takes the primary raw material of following weight proportions to be prepared from (often
Part takes 10g):30 parts of Artemisia anomala, 30 parts of row night, 25 parts of latifolious rush rhizome, 20 parts of rascal, 28 parts of caulis clematidis armandii, 40 parts of the bighead atractylodes rhizome, Ligusticum wallichii 40
Part, 18 parts of radix bupleuri, 14 parts of safflower, 28 parts of rhizoma cyperi.
The preparation method of above-mentioned Chinese medicine composition, step is:
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 40 minutes slowly as low baking temperature on tile, taking-up dries in the air cool, with grinding
Alms bowl pulverization, crosses 130 mesh sieves;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar is row night, bavin
Recklessly with 3 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 5 times, more than 80 DEG C of bulk drug weight
Water extraction 80 minutes, crosses 200 mesh screen packs, obtains decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 120 mesh sieves, plus 40 DEG C of warm water soaks 30 minutes, intense fire is fried open, and is turned slow fire and is added
Heat distillation equipment collects distillate or is passed through steam distillation 70 minutes, volatile oil is together distilled with water, collects and steams
Distillate, stands 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, and safflower is added in fluid and is heated to 150 DEG C, 6 are kept
Minute sterilizing, is cooled to room temperature, after be distributed into air-tight bottle and obtain external application application volatile oil.
A kind of Chinese medicine composition for treating newborn addiction of embodiment 3, takes the primary raw material of following weight proportions to be prepared from (often
Part takes 20g):23 parts of Artemisia anomala, 23 parts of row night, 20 parts of latifolious rush rhizome, 13 parts of rascal, 15 parts of caulis clematidis armandii, 33 parts of the bighead atractylodes rhizome, Ligusticum wallichii 30
Part, 13 parts of radix bupleuri, 9 parts of safflower, 23 parts of rhizoma cyperi.
The preparation method of above-mentioned Chinese medicine composition, step is:
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 25 minutes slowly as low baking temperature on tile, taking-up dries in the air cool, with grinding
Alms bowl pulverization, crosses 135 mesh sieves;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar is row night, bavin
Recklessly with 1.5 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 2 times, more than 80 DEG C of bulk drug weight
Water extraction 50 minutes, crosses 140 mesh screen packs, obtains decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 90 mesh sieves, plus 33 DEG C of warm water soaks 30 minutes, intense fire is fried open, and turns slow fire heating
Distillate is collected with distillation equipment or steam distillation is passed through 55 minutes, volatile oil is together distilled with water, collects distillation
Liquid, stands 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, and safflower is added in fluid and is heated to 100 DEG C, is kept for 6 points
Clock sterilizing, is cooled to room temperature, after be distributed into air-tight bottle obtain external application application volatile oil.
A kind of Chinese medicine composition for treating newborn addiction of embodiment 4, takes the primary raw material of following weight proportions to be prepared from (often
Part takes 15g):26 parts of Artemisia anomala, 28 parts of row night, 22 parts of latifolious rush rhizome, 18 parts of rascal, 18 parts of caulis clematidis armandii, 38 parts of the bighead atractylodes rhizome, Ligusticum wallichii 35
Part, 15 parts of radix bupleuri, 11 parts of safflower, 25 parts of rhizoma cyperi.
The preparation method of above-mentioned Chinese medicine composition, step is:
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 35 minutes slowly as low baking temperature on tile, taking-up dries in the air cool, with grinding
Alms bowl pulverization, crosses 145 mesh sieves;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar is row night, bavin
Recklessly with 2.5 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 4 times, more than 80 DEG C of bulk drug weight
Water extraction 70 minutes, crosses 180 mesh screen packs, obtains decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 110 mesh sieves, plus 38 DEG C of warm water soaks 30 minutes, intense fire is fried open, and is turned slow fire and is added
Heat distillation equipment collects distillate or is passed through steam distillation 65 minutes, volatile oil is together distilled with water, collects and steams
Distillate, stands 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, and safflower is added in fluid and is heated to 130 DEG C, 6 are kept
Minute sterilizing, is cooled to room temperature, after be distributed into air-tight bottle and obtain external application application volatile oil.
The woods XX of model case two, female, 29 years old, Qingdao personage, in July, 2012 gave birth to a lovely baby, 2013
Year, September part gave child wean, and after weaning 1 month, patient feels breast secret anguish or shouting pain, fixed pain suddenly.Originally it is thought as
Baby's wean is just given, the milk that rises does not take notice of very much that shouting pain is increasingly severe after 2 months, and discovery lump is touched with hand premenstrual
Have a lump, and premenstrual lump increases, and reduces after and softens, with irregular menstruation, dysmenorrhoea etc. disease.Pink tongue tongue is white, and arteries and veins is thin
Moisten.The soreness of waist is weak, and few and color is light through water, household have purchased the Chinese medicine composition of the present invention of 3 courses for the treatment of to patient.
Take and use cooperatively 4 resulting composition of embodiment after 5 days, tingling sensation mitigates, and continues to take 1 course for the treatment of, patient
Self-induction is fully recovered, and 2 courses for the treatment of are taken without recurrence again after recovery from illness, and premenstrual lump disappears, and waist does not ache, also not dysmenorrhoea.
A kind of Chinese medicine composition for treating newborn addiction of embodiment 5, takes the primary raw material of following weight proportions to be prepared from (often
Part takes 30g):24 parts of Artemisia anomala, 25 parts of row night, 21 parts of latifolious rush rhizome, 15 parts of rascal, 16 parts of caulis clematidis armandii, 35 parts of the bighead atractylodes rhizome, Ligusticum wallichii 33
Part, 14 parts of radix bupleuri, 10 parts of safflower, 24 parts of rhizoma cyperi.
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 20-40 minutes slowly as low baking temperature on tile, taking-up dries in the air cool,
Mortar pulverization is used, 140 mesh sieves are crossed;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar is row night, bavin
Recklessly with 2 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 3 times, more than 80 DEG C of bulk drug weight
Water extraction 60 minutes, crosses 160 mesh screen packs, obtains decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 100 mesh sieves, plus 35 DEG C of warm water soaks 30 minutes, intense fire is fried open, and is turned slow fire and is added
Heat distillation equipment collects distillate or is passed through steam distillation 60 minutes, volatile oil is together distilled with water, collects and steams
Distillate, stands 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, and safflower is added in fluid and is heated to 120 DEG C, 6 are kept
Minute sterilizing, is cooled to room temperature, after be distributed into air-tight bottle and obtain external application application volatile oil.
The clinical practice of the Chinese medicine composition of the newborn addiction of the gained treatment of 1 embodiment of test example 5:200 are screened in 4 hospitals
Patient, oldest 45 years old, minimal ages 20 years old, average age 32 years old.1 week before experiment, the crowd is continuously seen
Examine, record symptom and change, be randomly divided into two groups, experimental group and control group, experimental group are taken the products obtained therefrom of embodiment 5, compareed
Group takes other medicines (conventional medication such as Ru Pi Ling", 'rupikang ' capsule).Application method is:Gained granule is 1 small after the meal three
When after take, take with warm water, each 3-5 grams, gained volatile oil is applied at mammary swelling, one is for several times, it is appropriate every time, 7
It is a course for the treatment of.Curative effect situation criterion:Cure:Take and using this product after, malaise symptoms have clear improvement, pain
It is basic to disappear;Effectively:Take and using this product after, malaise symptoms make moderate progress, and pain has mitigated;It is invalid:Take and use
After this product, malaise symptoms are unchanged.As a result as shown in table 1-2.
Table 1
Therapeutic effect:Take and using Chinese medicine composition effective percentage 98% of the present invention, 23% is higher by than control group.Effect is bright
It is aobvious to be better than control group.
Table 2:
Clinical tests prove that, take and using Chinese medicine composition of the present invention and the medicine phase for taking the newborn addiction of other treatment
Than, control that recurrence rate after healing is low, treatment means are more fully thorough, have no side effect during use, can be with while treatment newborn addiction
The symptoms such as pain, poor appetite, irregular menstruation, the endocrinopathy that alleviation is brought by newborn addiction.Clinical tests prove that, the present invention
Chinese medicine composition effective percentage 98%, most of newborn addiction patients were in medication 5 days or so, and pain symptom has obvious mitigation.In the present invention
Drug composition is a kind of medicine for safely and effectively treating newborn addiction.
Claims (18)
1. a kind of preparation method for the Chinese medicine composition for treating newborn addiction, it is characterised in that:The raw material of following weight proportions is taken to prepare
Form:15-30 parts of Artemisia anomala, night 20-30 parts of row, 18-25 parts of latifolious rush rhizome, 10-20 parts of rascal, 9-28 parts of caulis clematidis armandii, bighead atractylodes rhizome 30-
40 parts, 25-40 parts of Ligusticum wallichii, 9-18 parts of radix bupleuri, 6-14 parts of safflower, 15-28 parts of rhizoma cyperi;
Step is as follows:
(1) Artemisia anomala, latifolious rush rhizome, rascal and caulis clematidis armandii are dried 20-40 minutes slowly as low baking temperature on tile, taking-up dries in the air cool, with grinding
Alms bowl pulverization, crosses 130-150 mesh sieves;
(2) row night, radix bupleuri and rhizoma cyperi are placed in non iron container, add the vexed profit of light-coloured vinegar, the consumption of light-coloured vinegar be row night, radix bupleuri and
1-3 times of the total consumption of rhizoma cyperi;
(3) bulk drug obtained by step (2) is soaked 30 minutes, water consumption is 1-5 times of bulk drug weight, more than 80 DEG C water
Carry 40-80 minutes, cross 100-200 mesh screen packs, obtain decoction;
(4) by medicine liquid heating obtained by step (3) to seething with excitement, continue to filter after 1.5 hours, filtrate is concentrated into relative density and is
1.20, let cool;
(5) gained smalls in step (1) is added in filtrate obtained by step (4), dries, particle is made;
(6) bighead atractylodes rhizome, Ligusticum wallichii were smashed into 80-120 mesh sieves, plus 30-40 DEG C of warm water soaks 30 minutes, intense fire is fried open, and turns slow fire
Heating distillation equipment collects distillate or is passed through steam distillation 50-70 minutes, volatile oil is together distilled with water, receives
Collect distillate, stand 30 minutes, distillate, which is cooled to after 40 DEG C, takes upper strata fluid, safflower is added in fluid and is heated to 80 DEG C -150
DEG C, keep 6 minutes sterilizings, be cooled to room temperature, after be distributed into air-tight bottle obtain external application application volatile oil.
2. preparation method according to claim 1, it is characterised in that:Each raw material is as follows:23-26 parts of Artemisia anomala, row night 23-
28 parts, 20-22 parts of latifolious rush rhizome, 13-18 parts of rascal, 15-18 parts of caulis clematidis armandii, 33-38 parts of the bighead atractylodes rhizome, 30-35 parts of Ligusticum wallichii, radix bupleuri 13-
15 parts, 9-11 parts of safflower, 23-25 parts of rhizoma cyperi.
3. preparation method according to claim 1, it is characterised in that:Each raw material is as follows:24 parts of Artemisia anomala, 25 parts of row night,
21 parts of latifolious rush rhizome, 15 parts of rascal, 16 parts of caulis clematidis armandii, 35 parts of the bighead atractylodes rhizome, 33 parts of Ligusticum wallichii, 14 parts of radix bupleuri, 10 parts of safflower, 24 parts of rhizoma cyperi.
4. preparation method according to claim 1, it is characterised in that:Step (1) is by Artemisia anomala, latifolious rush rhizome, rascal and river
Akebi is dried 25-35 minutes slowly as low baking temperature on tile.
5. preparation method according to claim 4, it is characterised in that:Step (1) is by Artemisia anomala, latifolious rush rhizome, rascal and river
Akebi is dried 30 minutes slowly as low baking temperature on tile.
6. preparation method according to claim 1, it is characterised in that:Step (1) mortar pulverization, crosses 140 mesh sieves.
7. preparation method according to claim 1, it is characterised in that:The consumption of step (2) light-coloured vinegar is row night, radix bupleuri and perfume (or spice)
1.5-2.5 times of attached total consumption.
8. preparation method according to claim 7, it is characterised in that:The consumption of step (2) light-coloured vinegar is row night, radix bupleuri and perfume (or spice)
2 times of attached total consumption.
9. preparation method according to claim 1, it is characterised in that:Step (3) water consumption is the 2-4 of bulk drug weight
Times.
10. preparation method according to claim 9, it is characterised in that:Step (3) water consumption is 3 times of bulk drug weight.
11. preparation method according to claim 1, it is characterised in that:The water extraction 60 minutes of more than (3) 80 DEG C of step.
12. preparation method according to claim 1, scheme preferably is:Step (3) crosses 140-180 mesh screen packs.
13. preparation method according to claim 12, scheme preferably is:Step (3) crosses 160 mesh screen packs.
14. preparation method according to claim 1, it is characterised in that:The bighead atractylodes rhizome, Ligusticum wallichii were smashed 100 mesh by step (6)
Sieve.
15. preparation method according to claim 1, it is characterised in that:Step (6) is passed through steam distillation 55-65 minutes.
16. preparation method according to claim 15, it is characterised in that:Step (6) is passed through steam distillation 60 minutes.
17. preparation method according to claim 1, it is characterised in that:Safflower is added in step (6) fluid and is heated to 100-
130℃。
18. preparation method according to claim 17, it is characterised in that:Safflower is added in step (6) fluid and is heated to 120
℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410269639.XA CN104435509B (en) | 2014-06-18 | 2014-06-18 | A kind of Chinese medicine composition for treating newborn addiction and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410269639.XA CN104435509B (en) | 2014-06-18 | 2014-06-18 | A kind of Chinese medicine composition for treating newborn addiction and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104435509A CN104435509A (en) | 2015-03-25 |
CN104435509B true CN104435509B (en) | 2017-10-03 |
Family
ID=52882770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410269639.XA Expired - Fee Related CN104435509B (en) | 2014-06-18 | 2014-06-18 | A kind of Chinese medicine composition for treating newborn addiction and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435509B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732528A (en) * | 2010-02-10 | 2010-06-16 | 李蕴 | Chinese medicament for treating of hyperplasia of mammary gland |
-
2014
- 2014-06-18 CN CN201410269639.XA patent/CN104435509B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732528A (en) * | 2010-02-10 | 2010-06-16 | 李蕴 | Chinese medicament for treating of hyperplasia of mammary gland |
Non-Patent Citations (2)
Title |
---|
乳癖的辨证论治体会;郭萍;《中医函授通讯》;19970815;第16卷(第4期);第24页左栏第2段 * |
乳腺增生病中医治疗近况;黄海锋等;《湖南中医学院学报》;19960930;第16卷(第3期);第72-74页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104435509A (en) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
CN104187172B (en) | Functional feed for treating enterogastritis diseases of turtles and preparation method of functional feed | |
CN103432532A (en) | Traditional Chinese medicine granules for treating nodules of breast and preparation method thereof | |
CN102755596A (en) | Traditional Chinese medicine for treating phlegm-dampness hyperplasia of mammary glands and preparation method thereof | |
CN103751482A (en) | Medicine for treating postpartum abdominal pain and preparation method thereof | |
CN103638475A (en) | Traditional Chinese medicinal spray for treating lump in breast and preparation method thereof | |
CN104435509B (en) | A kind of Chinese medicine composition for treating newborn addiction and preparation method thereof | |
CN105617268A (en) | Medicine for treating scale keratinization type beriberi | |
CN104740263A (en) | Traditional Chinese medicinal composition for treating galactocele and preparation method thereof | |
CN105267696A (en) | Traditional Chinese medicine pill for treating kidney-yin-deficiency type chronic pyelonephritis and preparation method of traditional Chinese medicine pill for treating kidney-yin-deficiency type chronic pyelonephritis | |
CN103212026A (en) | Traditional Chinese medicine for treating cholelithiasis as well as preparation method and taking method thereof | |
CN103349108A (en) | Warming-yang and tonifying-pleen healthy team cream and preparation method | |
CN101279040B (en) | Chinese medicinal active anti-cancer vaccine and method of preparing the same | |
CN104606605A (en) | Traditional Chinese medicine composition for treating breast hyperplasia and preparation method for traditional Chinese medicine composition | |
CN105998859A (en) | Traditional Chinese medicinal composition for treating liver and gallbladder damp-heat type pancreatitis | |
CN105596980A (en) | Drug for treating angina pectoris and preparation method thereof | |
CN104547999A (en) | Oil for postpartum sweating | |
CN104840758A (en) | Traditional Chinese medicine composition for treating dysmenorrheal and preparation method of traditional Chinese medicine composition | |
CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
CN104435525A (en) | Traditional Chinese medicine composition for preventing and treating bacterial endocarditis and preparation method of traditional Chinese medicine composition | |
CN103690816A (en) | Traditional Chinese medicinal composition for eliminating spleen insufficiency, phlegm dampness and breast cystic hyperplasia and preparation method thereof | |
CN108543031A (en) | A kind of antipsoriatics object and preparation method thereof | |
CN101700316A (en) | Traditional Chinese medicine capsule for treating psoriasis | |
CN105902745A (en) | Spleen and stomach strengthening unguent for navel moxibustion and preparation method | |
CN104887862A (en) | TCM (traditional Chinese medicine) preparation for coronary heart disease and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171003 Termination date: 20210618 |